Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Jandial

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
QJM : Monthly Journal of the Association of Physicians|September 15, 2018
Pulmonary arteriovenous malformationsR Sandal, A Jandial, K Mishra, et al.
QJM : Monthly Journal of the Association of Physicians|February 5, 2019
Mees linesR Sandal, P Porchezhian, K Mishra, et al.
Blood Advances|December 4, 2018
Hemophilia in the developing world: transforming lives through international collaborationA Jandial, K Mishra, R Sandal, et al.
Gynecologic Oncology|March 26, 2017
A phase I pharmacokinetic study of intraperitoneal bortezomib and carboplatin in patients with persistent or recurrent ovarian cancer: An NRG Oncology/Gynecologic Oncology Group studyDanielle A Jandial, William E Brady, Stephen B Howell, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
QJM : Monthly Journal of the Association of Physicians|September 15, 2018
Pulmonary arteriovenous malformationsR Sandal, A Jandial, K Mishra, et al.
QJM : Monthly Journal of the Association of Physicians|February 5, 2019
Mees linesR Sandal, P Porchezhian, K Mishra, et al.
Blood Advances|December 4, 2018
Hemophilia in the developing world: transforming lives through international collaborationA Jandial, K Mishra, R Sandal, et al.
Gynecologic Oncology|March 26, 2017
A phase I pharmacokinetic study of intraperitoneal bortezomib and carboplatin in patients with persistent or recurrent ovarian cancer: An NRG Oncology/Gynecologic Oncology Group studyDanielle A Jandial, William E Brady, Stephen B Howell, et al.
Pageof 2